Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents-Reference-Cited by-同舟云学术

Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents

Published:2017-11 Issue:9 Volume:27 Page:771-781
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Sallee Floyd¹,Kohegyi Eva²,Zhao Joan²,McQuade Robert²,Cox Kevin²,Sanchez Raymond²,van Beek Alet³,Nyilas Margaretta²,Carson William²,Kurlan Roger⁴

Affiliation:

1. Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio.

2. Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.

3. Mylan, Canonsburg, Pennsylvania.

4. Atlantic Neuroscience Institute, Overlook Medical Center, Summit, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2016.0026

Reference34 articles.

1. Abilify® (aripiprazole): Full Prescribing Information. Tokyo, Japan, Otsuka Pharmaceutical Co., Ltd., 2016.

2. A National Profile of Tourette Syndrome, 2011–2012

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral aripiprazole in the treatment of tic disorders in China: a cost-effectiveness analysis based on a mapping algorithm derived from a Chinese children and adolescents population;Child and Adolescent Psychiatry and Mental Health;2024-08-07

2. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms;Expert Review of Neurotherapeutics;2024-07-21

3. Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette’s disorder;Child and Adolescent Psychiatry and Mental Health;2024-07-18

4. Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders;2024-05-24

5. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis;Movement Disorders;2024-01-21